IFN-γ could potentially increase the expression of PD-L1 in tumor cells, which biding with PD-1, in resulting inhibiting activation, expansion, and effector functions of CD8+ T cells and helps cancer cells evade immune destruction so that to contribute to tumor immune evasion. This evidence concerns the gene CD8A and cancer.